Heartbeat: is postmenopausal hormone therapy a risk factor or preventative therapy for cardiovascular disease in women?

Suppr

超能文献

作者信息

Otto Catherine M

机构信息

Division of Cardiology, University of Washington, Seattle, Washington, USA

出版信息

Heart. 2021 Jul;107(14):1103-1105. doi: 10.1136/heartjnl-2021-319791.

DOI:10.1136/heartjnl-2021-319791

PMID:34172563

Abstract

摘要

相似文献

Heartbeat: is postmenopausal hormone therapy a risk factor or preventative therapy for cardiovascular disease in women?

Heart. 2021 Jul;107(14):1103-1105. doi: 10.1136/heartjnl-2021-319791.

Are we there yet? Menopausal hormone therapy for primary cardiovascular disease prevention.

Heart. 2021 Jul;107(14):1106-1108. doi: 10.1136/heartjnl-2020-318390. Epub 2021 May 24.

Postmenopausal hormone therapy for cardiovascular health: the evolving data.

Heart. 2021 Jul;107(14):1115-1122. doi: 10.1136/heartjnl-2019-316323. Epub 2021 Feb 22.

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Recommendation Statement.

Am Fam Physician. 2018 Apr 15;97(8):Online.

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women.

Am Fam Physician. 2018 Apr 15;97(8):541-542.

The use of hormone replacement therapy in postmenopausal women with type 2 diabetes.

J Womens Health Gend Based Med. 2001 Apr;10(3):241-55. doi: 10.1089/152460901300139998.

Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.

Climacteric. 2011 Jun;14(3):302-20. doi: 10.3109/13697137.2011.570590.

Benefits of hormone replacement therapy in postmenopausal women.

J Am Acad Nurse Pract. 2007 Dec;19(12):635-41. doi: 10.1111/j.1745-7599.2007.00269.x.

Postmenopausal hormone replacement therapy after the Women's Health Initiative.

JAAPA. 2005 Jan;18(1):30-7; quiz 39-40. doi: 10.1097/01720610-200501000-00005.

Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.

J Cardiovasc Risk. 2002 Dec;9(6):309-14. doi: 10.1097/01.hjr.00000445155.34172.04.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Heartbeat: is postmenopausal hormone therapy a risk factor or preventative therapy for cardiovascular disease in women?

Heart. 2021 Jul;107(14):1103-1105. doi: 10.1136/heartjnl-2021-319791.

Are we there yet? Menopausal hormone therapy for primary cardiovascular disease prevention.

Heart. 2021 Jul;107(14):1106-1108. doi: 10.1136/heartjnl-2020-318390. Epub 2021 May 24.

Postmenopausal hormone therapy for cardiovascular health: the evolving data.

Heart. 2021 Jul;107(14):1115-1122. doi: 10.1136/heartjnl-2019-316323. Epub 2021 Feb 22.

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Recommendation Statement.

Am Fam Physician. 2018 Apr 15;97(8):Online.

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women.

Am Fam Physician. 2018 Apr 15;97(8):541-542.

The use of hormone replacement therapy in postmenopausal women with type 2 diabetes.

J Womens Health Gend Based Med. 2001 Apr;10(3):241-55. doi: 10.1089/152460901300139998.

Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.

Climacteric. 2011 Jun;14(3):302-20. doi: 10.3109/13697137.2011.570590.

Benefits of hormone replacement therapy in postmenopausal women.

J Am Acad Nurse Pract. 2007 Dec;19(12):635-41. doi: 10.1111/j.1745-7599.2007.00269.x.

Postmenopausal hormone replacement therapy after the Women's Health Initiative.

JAAPA. 2005 Jan;18(1):30-7; quiz 39-40. doi: 10.1097/01720610-200501000-00005.

Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.

J Cardiovasc Risk. 2002 Dec;9(6):309-14. doi: 10.1097/01.hjr.00000445155.34172.04.